Navigation Links
Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field
Date:11/9/2009

e directions Sunil K. Aggarwal, PhD; Gregory T. Carter, MD, MS; Mark D. Sullivan, MD, PhD; Craig ZumBrunnen, PhD; Richard Morrill, PhD; Jonathan D. Mayer, PhD click this link http://tinyurl.com/ydqwtd2

To purchase a reprint of Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State Sunil K. Aggarwal, PhD, MD Candidate; Gregory T. Carter, MD, MS; Mark D. Sullivan, MD, PhD; Craig ZumBrunnen, PhD; Richard Morrill, PhD; Jonathan D. Mayer, PhD click this link http://tinyurl.com/y9yk9zq .

Journal of Opioid Management, a professional, peer-reviewed publication is designed to meet the challenge faced by physicians as they prescribe powerful, quality-of-life enhancing painkillers to their patients. Filling a long standing gap in medical literature, it addresses all aspects of opioid use and safe management and does so at a time when the federal spotlight has been switched on to the rising problem of abuse and addiction tied to these prescription painkillers.

Journal of Opioid Management has become the unchallenged journal of record for those in the field today. For more information about the journal, visit http://www.opioidmanagement.com . To subscribe to the online edition please visit http://ejournal.opioidmanagement.com or call the circulation department at 781-899-2702 ext 108. 

    Contact: Richard A. Devito, Jr.
    Journal of Opioid Management
    781-899-2702 Ext. 107
    radjr@pnpco.com

SOURCE Journal of Opioid Management


'/>"/>
SOURCE Journal of Opioid Management
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
2. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
3. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
4. Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting
5. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
6. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
7. DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
8. Watson to Present at Credit Suisse Healthcare Conference
9. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
10. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
11. BD to Present at Investor Healthcare Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ass. and LONDON, Nov. 20 ...y announced that it has received 510(k) clearance ...nd CE Mark approval to market its WallFlex® F... malignant esophageal strictures (obstructions) ca...resectable esophageal cancer. ,, (Photo: htt...
(Date:11/20/2009)...n., Nov. 20 Smith &...pleased to announce the signing of a technology de...nt of Defense that may lead to the creation of a f...the treatment of the limbs of soldiers who sustain...e Advanced Research Projects Agency (DARPA), the c...
(Date:11/19/2009)... Colo., Nov. 19 In a ser...xperience, Heska Corporation (Nasdaq: HSKA ) ("He...of its new and improved website. The upgraded sit...ign and programming to align the site with the com...,, (Logo: http://www.newscom.com/cgi-bin/prnh...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Watchful Waiting Works for Older Men With Prostate Cancer 57270 1Watchful Waiting Works for Older Men With Prostate Cancer 57270 2Watchful Waiting Works for Older Men With Prostate Cancer 57270 3FDA Approves 4 Swine Flu Vaccines 57268 1FDA Approves 4 Swine Flu Vaccines 57268 2FDA Approves 4 Swine Flu Vaccines 57268 3FDA Approves 4 Swine Flu Vaccines 57268 4U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 1U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 2U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 3U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 4U S FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine 57266 5
...al, Inc., the largest,privately held spinal implan...the first FLEXUS(TM) Interspinous Spacers have bee...ion ("IDE") recently granted to Globus by Dr.,Dona...M) Spacer is placed with a unilateral approach bet... to the surrounding musculature,and tissue. FLEXUS...
... Clinical Trials,Bootcamp announces its inaugural ...rdinators, clinical research staff and other parti... Raton at the Boca Resort from May,14-17th, 2009. ...nitors and,other industry personnel will present i...s into a practice, as well as how to take an exist...
Other Medicine Technology:First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2
(Date:11/20/2009)... LAS VEGAS, Nov. 20 The...ive Director of the Nevada Health Care Association... commends and thanks Senate Majority Leader Harry ...p closer toward our goal of protecting every Nevad...care, and preserving the strength and viability of...
(Date:11/20/2009)...orial published online November 20 in the Journal...xaggerated fears and hopes that often appear in ne...ides guidance for both the media and journals to h....D., M.S., and Steven Woloshin, M.D., M.S., of Cen...stitute for Health Policy and Clinical Practice in...
(Date:11/20/2009)...ood pressure readings in children with chronic kid...n during doctor,s office visits increasing a chil...research from Johns Hopkins Children,s Center and ...rs online in the Journal of American Society of Ne...e measurements obtained during regular doctor visi...
(Date:11/20/2009)... Based out of Dallas, TX, the new ...uality products that are made in the USA. , ... 2009 -- blue sky scrubs is an independent medical...ty, design, production and distribution of hospita...y selling their products via their online boutique...
(Date:11/20/2009)... save up to one-third buying 90-day supply, study ...s) -- Buying a three-month supply of prescription ...-month supply, according to a new study. , U.S....for 395 drugs between 2000 and 2005, and found tha... of a one-month supply saved an average 29 percent...
Breaking Medicine News(10 mins):Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:Three-Month Supply Lowers Drug Costs 2
... 2009)South Florida has the second most populous J... people traditionally settled in South Florida for...friends and family and to retire. Nonetheless, the...Dr. Ira M. Sheskin, from the department of Geograp...
...recent CBS 60 Minutes TV program drew considerable...ed wine molecule believed to largely be responsibl... far more people living beyond 100 years and exhib...nce. , , (Photo: http://www.newscom.com/cgi-bin...
...p reduce urban violence , , TUESDAY, March...increase when excess drinking occurs near a place ... University of Pennsylvania researchers. , "Indi...sier targets or they were shot as the victims of o...
...n Corporation (NYSE: OME ), the nation,s leading...eal products, today reported net income of $12.6 m...ecember 31, 2008, compared with net income of $12....ar ended December 31, 2008, the Company had revenu...
...sa Laboratories, Inc. (Nasdaq: MLAB ), a supplie...d manufacturing quality control applications, toda...n to the position of Chief Executive Officer (CEO)...ns of CEO and Treasurer, but will retain his posit...
...allenges of packaging traceability posed by regula...ennedy Group , a leader in label, packaging , pro...es its unique placard identification reusable labe...tal regulations, medical waste and sharps waste (n...
Other Medicine News:Health News:UM study reveals demographic trend of the Jewish population in Broward County 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 3Health News:Shootings Linked to Alcohol-to-Go Outlets, Study Finds 2Health News:Omega Protein Reports 2008 Results 2Health News:Omega Protein Reports 2008 Results 3Health News:Omega Protein Reports 2008 Results 4Health News:Omega Protein Reports 2008 Results 5Health News:Mesa Labs Announces the Appointment of New CEO 2Health News:Mesa Labs Announces the Appointment of New CEO 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 2Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 4
Albumin (BCP-DIMENSION)
Phosohorus (Inorganic) Liquid
Bilirubin (Total)
LDH
Medicine Products: